chr9-137169009-C-T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000371542.3(LRRC26):c.850G>A(p.Gly284Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000074 in 1,500,266 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G284D) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000371542.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LRRC26 | NM_001013653.3 | c.850G>A | p.Gly284Ser | missense_variant | 2/2 | ENST00000371542.3 | NP_001013675.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LRRC26 | ENST00000371542.3 | c.850G>A | p.Gly284Ser | missense_variant | 2/2 | 1 | NM_001013653.3 | ENSP00000360597 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000336 AC: 51AN: 151826Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000972 AC: 10AN: 102886Hom.: 0 AF XY: 0.000103 AC XY: 6AN XY: 58032
GnomAD4 exome AF: 0.0000445 AC: 60AN: 1348440Hom.: 0 Cov.: 30 AF XY: 0.0000286 AC XY: 19AN XY: 665414
GnomAD4 genome AF: 0.000336 AC: 51AN: 151826Hom.: 0 Cov.: 33 AF XY: 0.000378 AC XY: 28AN XY: 74146
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 14, 2021 | The c.850G>A (p.G284S) alteration is located in exon 2 (coding exon 2) of the LRRC26 gene. This alteration results from a G to A substitution at nucleotide position 850, causing the glycine (G) at amino acid position 284 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at